Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Yeon Lim | - |
dc.contributor.author | Yun, Ui Jeong | - |
dc.contributor.author | Lee, Min Sang | - |
dc.contributor.author | Kim, Myung Goo | - |
dc.contributor.author | Son, Sohee | - |
dc.contributor.author | Lee, Kyuri | - |
dc.contributor.author | Chae, Su Young | - |
dc.contributor.author | Lim, Dong Woo | - |
dc.contributor.author | Kim, Hong Tae | - |
dc.contributor.author | Kim, Sun Hwa | - |
dc.contributor.author | Jeong, Ji Hoon | - |
dc.date.accessioned | 2021-06-23T06:27:32Z | - |
dc.date.available | 2021-06-23T06:27:32Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2012-09 | - |
dc.identifier.issn | 0378-5173 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/31845 | - |
dc.description.abstract | Cancer chemotherapy is often limited, since more than one molecule is usually involved with the cancer pathogenesis. A combination of therapeutic drugs would be a promising approach to overcome the complexity of tumors. In this study, a conjugate (DA3) of deoxycholic acid and low molecular weight polyethylenimine (PEI 1.8 kDa), which has a property that mimics that of cell penetrating peptides (CPPs), was used for simultaneous delivery of an anticancer drug and siRNA. When complexed with siRNA, DA3 showed significantly higher target gene silencing efficiency than PEI 25 kDa. The gene silencing efficiency of DA3 was maintained even in the presence of endocytosis inhibitors, suggesting that the polymeric carrier can mediate an endocytosis-independent macromolecular transduction similar to CPPs. The capability of forming a micelle-like core-shell structure enables the conjugates to encapsulate and dissolve paclitaxel (PTX), a water-insoluble drug. The drug-loaded cationic micelles can then interact with siRNA to form stable complexes (PTX/DA3/siRNA). The PTX/DA3/siRNA showed significantly enhanced inhibition of cancer cell growth. When administered into tumor-bearing animals, the PTX/DA3/siRNA demonstrated significant suppression of tumor growth, providing potential usefulness in clinical settings. (C) 2012 Elsevier B.V. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lim, Dong Woo | - |
dc.identifier.doi | 10.1016/j.ijpharm.2012.04.083 | - |
dc.identifier.scopusid | 2-s2.0-84864140974 | - |
dc.identifier.wosid | 000306479400058 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF PHARMACEUTICS, v.434, no.1-2, pp.488 - 493 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF PHARMACEUTICS | - |
dc.citation.title | INTERNATIONAL JOURNAL OF PHARMACEUTICS | - |
dc.citation.volume | 434 | - |
dc.citation.number | 1-2 | - |
dc.citation.startPage | 488 | - |
dc.citation.endPage | 493 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | RNA INTERFERENCE | - |
dc.subject.keywordPlus | GENE-THERAPY | - |
dc.subject.keywordPlus | CANCER-CELLS | - |
dc.subject.keywordPlus | HUMAN BREAST | - |
dc.subject.keywordPlus | CO-DELIVERY | - |
dc.subject.keywordPlus | VEGF SIRNA | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | XIAP | - |
dc.subject.keywordPlus | ADENOCARCINOMA | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordAuthor | Biomimetic polymer | - |
dc.subject.keywordAuthor | Combined delivery | - |
dc.subject.keywordAuthor | siRNA | - |
dc.subject.keywordAuthor | Anticancer drug | - |
dc.subject.keywordAuthor | Combination cancer therapy | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S037851731200470X?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.